St. Mary Capital Begins Formal IPO Preparations Ahead of Anticipated 2026 Listing

St. Mary Capital Begins Formal IPO Preparations Ahead of Anticipated 2026 Listing GlobeNewswire October 21, 2025 LONDON, Oct. 21, 2025 (GLOBE NEWSWIRE) — St. Mary Capital has formally begun preparations for a potential initial public offering (IPO) in 2026. The move follows a period of sustained expansion and internal evaluation that confirmed the company's readiness […]

MEXC Launches SOL Launchpad: New Users Can Subscribe at 50% Off to Share 465 SOL

MEXC Launches SOL Launchpad: New Users Can Subscribe at 50% Off to Share 465 SOL GlobeNewswire October 21, 2025 VICTORIA, Seychelles, Oct. 21, 2025 (GLOBE NEWSWIRE) — MEXC, a leading global cryptocurrency exchange, has officially launched the SOL Launchpad. New users can subscribe with USDT at a 50% discount and share in a total pool

China heading to its next 5-year plan with green resolution

A report from China Daily https://mma.prnewswire.com/media/2801343/Image.jpg China has made remarkable progress in systemic governance for its green transition, with even more expected during the upcoming 15th Five-Year Plan period (2026-30), according to international experts. On Thursday, experts and officials from the China Council for International Cooperation on Environment and Development gathered in Beijing to share

ASSA ABLOY: Quarterly Report Q3 2025

Good growth and strong margin Third quarter — Net sales totaled SEK 38,146 M (37,418), with organic growth of 3% (0) and acquired net growth of 5% (4). Exchange rates affected sales by -6% (-3). — Organic sales growth was good in EMEIA, Entrance Systems, Global Technologies and Americas, while organic sales declined in Asia

Eleva advances CPV-104 into Phase 1b clinical testing in patients with C3G, following the successful completion of single ascending dose evaluation in healthy volunteers

CPV-104 is the only recombinant Factor H in clinical development and has received EU Orphan Drug Designation for C3G Eleva successfully completed the Single Ascending Dose part of the First-in-Human clinical trial evaluating CPV-104 in healthy volunteers The Safety Review Committee endorsed the study with no safety concerns identified across all four dose cohorts 18

LingoAce Named to 2026 GSV 150 for the Third Time

LingoAce has been named to the 2026 GSV 150, earning milestone recognition as one of the world's most transformational growth companies in digital learning and workforce skills-marking the third time the company has received this honor. Using a proprietary rubric-including revenue scale, revenue growth, user reach, geographic diversification, and margin profile-GSV evaluated more than 3,000

Getinge Interim Report July-September 2025: High organic sales growth and stronger margins despite geopolitical headwinds

“We demonstrated strength in the third quarter with significant organic growth, improved profitability and cash flow despite impacts from tariffs and negative currency effects,” says Mattias Perjos, President & CEO, Getinge. The medtech company's net sales increased organically by 9,5% while order intake rose by 4,7% organically. Acute Care Therapies continued to meet the higher

Eleva advances CPV-104 into Phase 1b clinical testing in patients with C3G, following the successful completion of single ascending dose evaluation in healthy volunteers

Eleva advances CPV-104 into Phase 1b clinical testing in patients with C3G, following the successful completion of single ascending dose evaluation in healthy volunteers GlobeNewswire October 21, 2025 CPV-104 is the only recombinant Factor H in clinical development and has received EU Orphan Drug Designation for C3G Eleva successfully completed the Single Ascending Dose part

Administrative and Cultural Experts from Craft Cities around the World Heading to Cheongju

Bringing together more than 50 market and craft experts and researchers from 12 countries around the world Researching Cheongju as a best practice for a craft-based experiential economy Administrative and cultural experts from around the world will gather in Cheongju, a city in the Republic of Korea that is currently hosts the Cheongju Craft Biennale

2025 Chery International User Summit: Shaping the Industry’s Future Through Co-Creation and Innovation

On October 21, 2025, the 2025Chery International User summit – a global gathering transcending geography and culture – was grandly held in Wuhu, China.With the theme “Co-Create, Co-Define,” the event brought together more than 3,000 participants from nearly 100 countries, including overseas users, dealership partners, members of the ESG Advisory Alliance, and international media representatives,

Scroll to Top